Oxford Industries (OXM) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 Nov, 2025Executive summary
First quarter fiscal 2025 net sales were $393 million, down 1.3% year-over-year, with operating income of $36.2 million, a 31% decrease from Q1 2024; adjusted EPS was $1.82, down from $2.66.
Results met guidance despite challenging market conditions, evolving U.S. trade policy, and new tariffs.
Growth at Lilly Pulitzer and Emerging Brands partially offset declines at Tommy Bahama and Johnny Was.
Gross margin remained above 64%, supported by supply chain diversification efforts.
SG&A expenses rose due to new store openings, higher employment, occupancy, and IT costs.
Financial highlights
Q1 consolidated net sales were $393 million (down 1.3% year-over-year), near the high end of guidance.
Adjusted gross margin contracted to 64.3% (down 110 bps), mainly due to higher freight, markdowns, and sales mix.
Adjusted operating profit was $39 million (9.8% margin) versus $57 million (14.4% margin) last year.
Adjusted net earnings per share were $1.82; GAAP EPS was $1.70, down from $2.42.
Cash from operations was negative $4 million, down from $33 million provided in the prior year.
Outlook and guidance
Full-year 2025 net sales expected between $1.475 billion and $1.515 billion, a 3% decline to flat versus 2024.
Adjusted EPS forecasted at $2.80–$3.20, down from $6.68 last year, reflecting $40 million in additional tariff costs.
Q2 2025 sales expected at $395–$415 million, with adjusted EPS of $1.05–$1.25.
Capital expenditures for 2025 projected at $120 million, mainly for the Lyons, Georgia distribution center and new stores.
Management remains cautious due to macroeconomic uncertainty, ongoing tariff impacts, and heightened promotional activity.
Latest events from Oxford Industries
- Q1 sales and earnings fell, but FY24 growth and investment are expected despite headwinds.OXM
Q1 20253 Feb 2026 - Earnings and margins fell on flat sales as guidance was cut and capex increased for growth.OXM
Q2 202520 Jan 2026 - Cost controls, sourcing shifts, and brand focus aim to drive a 2026 recovery after a tough 2025.OXM
28th Annual ICR Conference 202612 Jan 2026 - Q3 sales and earnings declined, with 2024 guidance lowered amid ongoing macro headwinds.OXM
Q3 202511 Jan 2026 - Strong brands, resilient margins, and strategic investments set the stage for 2025 growth.OXM
27th Annual ICR Conference 202510 Jan 2026 - 2024 sales and earnings fell; 2025 outlook flat with ongoing headwinds and strong capital returns.OXM
Q4 202526 Dec 2025 - $63.7M Q3 loss on flat sales, hit by $61M impairments and tariff-driven margin pressure.OXM
Q3 202612 Dec 2025 - Shareholders will vote on directors, auditor ratification, and executive pay, with a focus on governance.OXM
Proxy Filing1 Dec 2025 - Virtual annual meeting on June 24, 2025, with votes on directors, auditor, and compensation.OXM
Proxy Filing1 Dec 2025